TOOKAD(®) Soluble focal therapy: pooled analysis of three phase II studies assessing the minimally invasive ablation of localized prostate cancer

PURPOSE: To evaluate the 6-month effects of the recommended drug and light dosage in focal vascular-targeted photodynamic therapy (VTP) using TOOKAD(®) Soluble in patients with localized prostate cancer (LPCa). METHODS: We performed a pooled analysis of 117 men with LPCa, PSA <10 ng/mL, and Gleas...

Descripción completa

Detalles Bibliográficos
Autores principales: Azzouzi, A. R., Barret, E., Bennet, J., Moore, C., Taneja, S., Muir, G., Villers, A., Coleman, J., Allen, C., Scherz, A., Emberton, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480329/
https://www.ncbi.nlm.nih.gov/pubmed/25712310
http://dx.doi.org/10.1007/s00345-015-1505-8

Ejemplares similares

Ejemplares similares